Auron Therapeutics is a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease.
Market
Oncology and inflammatory disease
Location
NEWTON,
MA,
USA
Coinvestors
DCVC Bio, Apollo Health Ventures, Arkin Bio Ventures, BrightEdge, Casdin Capital, Franklin Berger, Mubadala Capital, Polaris Partners, Qiming Venture Partners USA